Bradley Parry, PhD

Chief Technology Officer at AI Therapeutics

Bradley Parry, PhD has a diverse work experience. In 2019, they were appointed as the Head of Artificial Intelligence at AI Therapeutics. Prior to that, from 2015 to 2019, they were a Post-doctoral associate at Yale University and the Howard Hughes Medical Institute. During their time there, they designed and implemented a range of experimental and novel computational approaches to study dynamical properties of the bacterial cytoplasm, which involved development of de novo image processing routines merged with development of statistical inference/deep learning methods to analyze resulting data sets.

Bradley Parry, PhD attained their Doctor of Philosophy (Ph.D.) from Yale University in 2015, where they studied MCDB - biology & physics. Bradley also earned a Master's Degree from Rutgers University - Camden in 2009, where they studied Molecular Biology & Bioinformatics.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


AI Therapeutics

1 followers

AI Therapeutics is an AI-driven company with a unique ability to match drugs to indications and prosecute through clinical development. AI Therapeutics’ revolutionary approach to drug discovery and development has advanced three drugs into clinical trials.


Industries

Employees

51-200

Links